Clinical Trial Update: Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Endostar in combination with chemotherapy and radiotherapy for non-small cell lung cancer has completed. The status update confirms c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Fudan University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED